| Product Code: ETC12345559 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of direct-acting antivirals for HCV in Cyprus have shown steady growth, with top exporters including Greece, Germany, Netherlands, Switzerland, and Vietnam in 2024. The market concentration, as measured by the HHI, remained at a moderate level in 2024, indicating a competitive market landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was a robust 10.34%, with a notable growth rate of 13.05% from 2023 to 2024, reflecting a strong demand for these pharmaceutical products in Cyprus.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus HCV Direct Acting Antiviral Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus HCV Direct Acting Antiviral Market - Industry Life Cycle |
3.4 Cyprus HCV Direct Acting Antiviral Market - Porter's Five Forces |
3.5 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Cyprus HCV Direct Acting Antiviral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus HCV Direct Acting Antiviral Market Trends |
6 Cyprus HCV Direct Acting Antiviral Market, By Types |
6.1 Cyprus HCV Direct Acting Antiviral Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Antibody, 2021 - 2031F |
6.1.4 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Viral Load, 2021 - 2031F |
6.1.5 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Genotyping, 2021 - 2031F |
6.2 Cyprus HCV Direct Acting Antiviral Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By NS3/4A Protease Inhibitors, 2021 - 2031F |
6.2.3 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By NS5A Polymerase Inhibitors, 2021 - 2031F |
6.2.4 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By NS5B Polymerase Inhibitors, 2021 - 2031F |
6.2.5 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By Combination Drugs, 2021 - 2031F |
6.3 Cyprus HCV Direct Acting Antiviral Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
6.3.3 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By Online Pharmacy, 2021 - 2031F |
6.3.4 Cyprus HCV Direct Acting Antiviral Market Revenues & Volume, By Retail Pharmacy, 2021 - 2031F |
7 Cyprus HCV Direct Acting Antiviral Market Import-Export Trade Statistics |
7.1 Cyprus HCV Direct Acting Antiviral Market Export to Major Countries |
7.2 Cyprus HCV Direct Acting Antiviral Market Imports from Major Countries |
8 Cyprus HCV Direct Acting Antiviral Market Key Performance Indicators |
9 Cyprus HCV Direct Acting Antiviral Market - Opportunity Assessment |
9.1 Cyprus HCV Direct Acting Antiviral Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Cyprus HCV Direct Acting Antiviral Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Cyprus HCV Direct Acting Antiviral Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Cyprus HCV Direct Acting Antiviral Market - Competitive Landscape |
10.1 Cyprus HCV Direct Acting Antiviral Market Revenue Share, By Companies, 2024 |
10.2 Cyprus HCV Direct Acting Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here